Literature DB >> 2168975

A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.

M A Whitt1, P Zagouras, B Crise, J K Rose.   

Abstract

We have recently described an assay in which a temperature-sensitive mutant of vesicular stomatitis virus (VSV; mutant tsO45), encoding a glycoprotein that is not transported to the cell surface, can be rescued by expression of wild-type VSV glycoproteins from cDNA (M. Whitt, L. Chong, and J. Rose, J. Virol. 63:3569-3578, 1989). Here we examined the ability of mutant G proteins to rescue tsO45. We found that one mutant protein (QN-1) having an additional N-linked oligosaccharide at amino acid 117 in the extracellular domain was incorporated into VSV virions but that the virions containing this glycoprotein were not infectious. Further analysis showed that virus particles containing the mutant protein would bind to cells and were endocytosed with kinetics identical to those of virions rescued with wild-type G protein. We also found that QN-1 lacked the normal membrane fusion activity characteristic of wild-type G protein. The absence of fusion activity appears to explain lack of particle infectivity. The proximity of the new glycosylation site to a sequence of 19 uncharged amino acids (residues 118 to 136) that is conserved in the glycoproteins of the two VSV serotypes suggests that this region may be involved in membrane fusion. The mutant glycoprotein also interferes strongly with rescue of virus by wild-type G protein. The strong interference may result from formation of heterotrimers that lack fusion activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168975      PMCID: PMC247981          DOI: 10.1128/JVI.64.10.4907-4913.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation.

Authors:  M J Gething; J M White; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

4.  Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions.

Authors:  J K Rose; C J Gallione
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

Review 5.  Membrane fusion proteins of enveloped animal viruses.

Authors:  J White; M Kielian; A Helenius
Journal:  Q Rev Biophys       Date:  1983-05       Impact factor: 5.318

6.  Pathway of vesicular stomatitis virus entry leading to infection.

Authors:  K S Matlin; H Reggio; A Helenius; K Simons
Journal:  J Mol Biol       Date:  1982-04-15       Impact factor: 5.469

7.  Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.

Authors:  J J Skehel; P M Bayley; E B Brown; S R Martin; M D Waterfield; J M White; I A Wilson; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins.

Authors:  H Garoff; A M Frischauf; K Simons; H Lehrach; H Delius
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

9.  Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein.

Authors:  J K Rose; J E Bergmann
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

10.  Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein.

Authors:  R Z Florkiewicz; A Smith; J E Bergmann; J K Rose
Journal:  J Cell Biol       Date:  1983-11       Impact factor: 10.539

View more
  32 in total

1.  Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion.

Authors:  Vanessa R Melanson; Ronald M Iorio
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry.

Authors:  M Perez; M Watanabe; M A Whitt; J C de la Torre
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.

Authors:  E O Freed; E L Delwart; G L Buchschacher; A T Panganiban
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

4.  Characterization of two temperature-sensitive mutants of coronavirus mouse hepatitis virus strain A59 with maturation defects in the spike protein.

Authors:  W Luytjes; H Gerritsma; E Bos; W Spaan
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G.

Authors:  D Odell; E Wanas; J Yan; H P Ghosh
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion.

Authors:  E Jeetendra; Clinton S Robison; Lorraine M Albritton; Michael A Whitt
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  The central proline of an internal viral fusion peptide serves two important roles.

Authors:  S E Delos; J M Gilbert; J M White
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence.

Authors:  A Hirano
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein.

Authors:  Lisa D Schlehuber; John K Rose
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.

Authors:  K R Steffy; F Wong-Staal
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.